21-Dehydro Clocortolone
|
- $1253.87 - $17009
- Product name: 21-Dehydro Clocortolone
- CAS: 61744-29-4
- MF: C22H26ClFO4
- MW: 408.89
- EINECS:
- MDL Number:MFCD31700611
- Synonyms:21-Dehydro Clocortolone;Pregna-1,4-dien-21-al, 9-chloro-6-fluoro-11-hydroxy-16-methyl-3,20-dioxo-, (6α,11β,16α)- (9CI)
6 prices
Selected condition：
Brand
- Biosynth
- TRC
Package
- 1mg
- 5mg
- 10mg
- 25mg
- 50mg
- ManufacturerBiosynth
- Product numberLCA74429
- Product description21-Dehydro clocortolone
- Packaging1mg
- Price$1253.87
- Updated2026-06-04
- Buy
- ManufacturerBiosynth
- Product numberLCA74429
- Product description21-Dehydro clocortolone
- Packaging5mg
- Price$3543.55
- Updated2026-06-04
- Buy
- ManufacturerBiosynth
- Product numberLCA74429
- Product description21-Dehydro clocortolone
- Packaging10mg
- Price$5669.7
- Updated2026-06-04
- Buy
- ManufacturerBiosynth
- Product numberLCA74429
- Product description21-Dehydro clocortolone
- Packaging25mg
- Price$10630.5
- Updated2026-06-04
- Buy
- ManufacturerBiosynth
- Product numberLCA74429
- Product description21-Dehydro clocortolone
- Packaging50mg
- Price$17009
- Updated2026-06-04
- Buy
- ManufacturerTRC
- Product numberD229170
- Product description21-DehydroClocortolone
- Packaging25mg
- Price$7425
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Biosynth | LCA74429 | 21-Dehydro clocortolone | 1mg | $1253.87 | 2026-06-04 | Buy |
| Biosynth | LCA74429 | 21-Dehydro clocortolone | 5mg | $3543.55 | 2026-06-04 | Buy |
| Biosynth | LCA74429 | 21-Dehydro clocortolone | 10mg | $5669.7 | 2026-06-04 | Buy |
| Biosynth | LCA74429 | 21-Dehydro clocortolone | 25mg | $10630.5 | 2026-06-04 | Buy |
| Biosynth | LCA74429 | 21-Dehydro clocortolone | 50mg | $17009 | 2026-06-04 | Buy |
| TRC | D229170 | 21-DehydroClocortolone | 25mg | $7425 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|